Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.01
-
NAV
₹49.35
-
Fund Started
12 Nov 2018
-
Fund Size
₹3514.02 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
1 Year
10.33%
-
3 Year
20.99%
-
5 Year
14.73%
-
Equity
92.30%
-
Cash
7.70%
-
Top 10 Holdings
Cipla Ltd. | 8.35% |
Ipca Laboratories Ltd. | 8.21% |
Sun Pharmaceutical Industries Ltd. | 8.14% |
Illumina Inc. (USA) | 7.59% |
Sai Life Sciences Ltd. | 6.88% |
Gland Pharma Ltd. | 6.54% |
Globus Medical Inc | 5.72% |
Apollo Hospitals Enterprise Ltd. | 4.81% |
Cohance Lifesciences Ltd. | 4.13% |
Vijaya Diagnostic Centre Ltd. | 3.60% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
